Real-time enrollment status for this melanoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 4:10 AM UTC
| NCT Number | NCT06594991 |
| Recruiting Status | Recruiting |
| Condition | Melanoma |
| Phase | PHASE2 |
| Target Enrollment | 88 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | May 14, 2026 (May 14, 2026) |
As of July 18, 2026: Clinical trial NCT06594991 is currently recruiting participants. This phase2 study for melanoma is actively seeking new participants at 12 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06594991 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06594991 was last updated May 14, 2026 (May 14, 2026). HelloStudys verifies this status automatically.